Latest TLC-2000 Update from Michael Look out bellow for this stock price.......... i sold my shares i got at 0.27 at 0.29... wont be buying again for awhile
_________________________________________________________
On July 13, 2015, Theralase received notice from Health Canada that the file was now under review and they would provide a response in 2 weeks; hence, Theralase revised our guidance to the end of July 2015.
On July 27, Theralase received a request for more information from Health Canada. Theralase responded back August 6, 2015 and as of today, Theralase has been informed that HC requires 45 days + 2 to 3 week time delay to respond back; hence, Theralase’s new guidance is end of 3Q2015 / beginning of 4Q2015.
If HC comes back with a new set of questions, Theralase’s new guidance will become end of 4Q2015.
Best Regards,
Michael Borovec
Director, Investor Relations
Theralase Technologies Inc.
Office: 416.699.5273 x222
Mobile: 647.230.5330
Fax: 416.699.5250
mborovec@theralase.com
www.theralase.com